Ventas, Inc. (NYSE:VTR)

Ventas, Inc. VTR

Real Estate - REIT - Healthcare Facilities - NYSE - US

Watchlist

$ 63.6

0.158 %

$ 27.7 B

Market Cap

-454.29

P/E

1. INTRINSIC VALUE

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders.[ Read More ]

The intrinsic value of one VTR stock under the base case scenario is HIDDEN Compared to the current market price of 63.6 USD, Ventas, Inc. is HIDDEN

VTR Intrinsic Value
HIDDEN

SHOW

2. FUNDAMENTAL ANALYSIS

Price Chart VTR

FINANCIALS

Annual
Quarterly

4.5 B REVENUE

Growth Rates

1Year 8.93%

3Years 5.82%

5Years 3.73%

7Years 3.89%

10Years 4.82%

665 M OPERATING INCOME

Growth Rates

1Year 46.48%

3Years 3.92%

5Years -5.03%

7Years 2.57%

10Years -2.26%

-41 M NET INCOME

Growth Rates

1Year -0.10%

3Years -3.00%

5Years -1.90%

7Years -0.88%

10Years -0.87%

1.12 B OPERATING CASH FLOW

Growth Rates

1Year -0.03%

3Years -8.25%

5Years -4.11%

7Years -2.81%

10Years -0.65%

-185 M INVESTING CASH FLOW

Growth Rates

1Year 78.51%

3Years -30.00%

5Years -9.43%

7Years 23.77%

10Years 17.62%

-544 M FINANCING CASH FLOW

Growth Rates

1Year -91.51%

3Years 25.21%

5Years 20.95%

7Years -30.21%

10Years -19.07%

1.24 B REVENUE

Growth Rates

1Year 8.93%

3Years 5.82%

5Years 3.73%

7Years 3.89%

10Years 4.82%

1.2 B OPERATING INCOME

Growth Rates

1Year 46.48%

3Years 3.92%

5Years -5.03%

7Years 2.57%

10Years -2.26%

22.8 M NET INCOME

Growth Rates

1Year -0.10%

3Years -3.00%

5Years -1.90%

7Years -0.88%

10Years -0.87%

354 M OPERATING CASH FLOW

Growth Rates

1Year -0.03%

3Years -8.25%

5Years -4.11%

7Years -2.81%

10Years -0.65%

-419 M INVESTING CASH FLOW

Growth Rates

1Year 78.51%

3Years -30.00%

5Years -9.43%

7Years 23.77%

10Years 17.62%

613 M FINANCING CASH FLOW

Growth Rates

1Year -91.51%

3Years 25.21%

5Years 20.95%

7Years -30.21%

10Years -19.07%

Balance Sheet Decomposition Ventas, Inc.

24.7 B ASSETS
14.9 B LIABILITIES

Current Assets	860 M
Cash & Short-Term Investments	509 M
Receivables	194 M
Other Current Assets	157 M
Non-Current Assets	3 B
Long-Term Investments	758 M
PP&E	-20.9 B
Other Non-Current Assets	23.1 B

Current Liabilities	1.11 B
Accounts Payable	957 M
Short-Term Debt	1.29 B
Other Current Liabilities	-1.14 B
Non-Current Liabilities	13.8 B
Long-Term Debt	13.8 B
Other Non-Current Liabilities	2.84 M

EFFICIENCY

Earnings Waterfall Ventas, Inc.

Revenue	4.5 B
Cost Of Revenue	3.73 B
Gross Profit	771 M
Operating Expenses	106 M
Operating Income	665 M
Other Expenses	706 M
Net Income	-41 M

RATIOS

17.14% GROSS MARGIN

Averages

1Year 17.14%

3Years 35.76%

5Years 41.89%

7Years 46.10%

10Years 49.85%

14.79% OPERATING MARGIN

Averages

1Year 14.79%

3Years 11.98%

5Years 14.78%

7Years 16.33%

10Years 18.44%

-0.91% NET MARGIN

Averages

1Year -0.91%

3Years -0.21%

5Years 4.43%

7Years 10.14%

10Years 11.80%

-0.43% ROE

Averages

1Year -0.43%

3Years -0.13%

5Years 1.62%

7Years 3.51%

10Years 4.06%

-0.17% ROA

Averages

1Year -0.17%

3Years -0.05%

5Years 0.69%

7Years 1.56%

10Years 1.78%

2.09% ROIC

Averages

1Year 2.09%

3Years 1.70%

5Years 2.58%

7Years 2.94%

10Years 3.20%

FREE CASH FLOW ANALYSIS

Free Cash Flow Analysis Ventas, Inc.

Net Income	-41 M
Depreciation & Amortization	1.17 B
Capital Expenditures	-259 M
Stock-Based Compensation	31 M
Change in Working Capital	-53.6 M
Others	-14.3 M
Free Cash Flow	935 M

3. WALL STREET ANALYSTS ESTIMATES

Wall Street Analysts Price Targets Ventas, Inc.

Wall Street analysts predict an average 1-year price target for VTR of $58.2 , with forecasts ranging from a low of $50 to a high of $71 .

VTR Lowest Price Target Wall Street Target

50 USD -21.38%

VTR Average Price Target Wall Street Target

58.2 USD -8.45%

VTR Highest Price Target Wall Street Target

71 USD 11.64%

4. DIVIDEND ANALYSIS

1.37% DIVIDEND YIELD

0.45 USD DIVIDEND PER SHARE

5. COMPETITION

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States.

155 USD

Undervalued 788.21%

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

31.9 USD

DOC

Undervalued 52.79%

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers.

56.3 USD

UHT

Undervalued 38.62%

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

9.46 USD

GMRE

Undervalued 9.61%

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.

87.3 USD

NHI

Undervalued 12.29%

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities.

36.9 USD

OHI

Overvalued 7.75%

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture.

17.5 USD

SBRA

Overvalued 3.52%

CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties.

27.9 USD

CTRE

Overvalued 8.03%

6. Ownership

Insider Ownership Ventas, Inc.

Summary
Transactions

Sold

0-3 MONTHS

21.7 M USD 2

3-6 MONTHS

3.96 M USD 3

6-9 MONTHS

1.67 M USD 3

9-12 MONTHS

0 USD 0

Bought

0 USD 0

0-3 MONTHS

0 USD 0

3-6 MONTHS

0 USD 0

6-9 MONTHS

0 USD 0

9-12 MONTHS

Date	Value	Insider	Amount	Avg Price
2 weeks ago Oct 30, 2024	Sell 2.27 M USD	CAFARO DEBRA A Chairman and CEO	- 34085	66.6669 USD
2 weeks ago Oct 29, 2024	Sell 8.02 M USD	CAFARO DEBRA A Chairman and CEO	- 121248	66.1677 USD
3 weeks ago Oct 25, 2024	Sell 397 K USD	CAFARO DEBRA A Chairman and CEO	- 6004	66.111 USD
3 weeks ago Oct 24, 2024	Sell 4.94 M USD	CAFARO DEBRA A Chairman and CEO	- 74763	66.0969 USD
2 months ago Sep 10, 2024	Sell 390 K USD	Bulgarelli Peter J. EVP OM&R-Ventas/Pres&CEO-LHS	- 6000	64.9904 USD
2 months ago Sep 11, 2024	Sell 97.9 K USD	Bulgarelli Peter J. EVP OM&R-Ventas/Pres&CEO-LHS	- 1500	65.2702 USD
2 months ago Sep 09, 2024	Sell 1.45 M USD	CAFARO DEBRA A Chairman and CEO	- 22690	63.8111 USD
2 months ago Sep 06, 2024	Sell 514 K USD	CAFARO DEBRA A Chairman and CEO	- 8154	63.0391 USD
2 months ago Sep 05, 2024	Sell 431 K USD	CAFARO DEBRA A Chairman and CEO	- 6827	63.196 USD
2 months ago Sep 04, 2024	Sell 228 K USD	CAFARO DEBRA A Chairman and CEO	- 3617	63.0485 USD
2 months ago Aug 26, 2024	Sell 22.5 K USD	Bulgarelli Peter J. EVP OM&R-Ventas/Pres&CEO-LHS	- 375	60.0113 USD
2 months ago Aug 27, 2024	Sell 429 K USD	Bulgarelli Peter J. EVP OM&R-Ventas/Pres&CEO-LHS	- 7125	60.1558 USD
2 months ago Aug 27, 2024	Sell 2.31 M USD	CAFARO DEBRA A Chairman and CEO	- 38434	60.1364 USD
2 months ago Aug 26, 2024	Sell 171 K USD	CAFARO DEBRA A Chairman and CEO	- 2854	60.016 USD
3 months ago Aug 08, 2024	Sell 1.18 M USD	Probst Robert F EVP and CFO	- 20000	58.8665 USD
3 months ago Aug 05, 2024	Sell 56.2 K USD	CAFARO DEBRA A Chairman and CEO	- 986	57.0328 USD
3 months ago Aug 06, 2024	Sell 2.3 M USD	CAFARO DEBRA A Chairman and CEO	- 40079	57.2932 USD
3 months ago Aug 02, 2024	Sell 13.1 K USD	CAFARO DEBRA A Chairman and CEO	- 229	57.0001 USD
3 months ago Aug 01, 2024	Sell 209 K USD	Bulgarelli Peter J. Pres&CEO-LHS/EVP Office-Ventas	- 3784	55.2375 USD
3 months ago Jul 30, 2024	Sell 37.9 K USD	Bulgarelli Peter J. Pres&CEO-LHS/EVP Office-Ventas	- 688	55.0226 USD
3 months ago Jul 31, 2024	Sell 167 K USD	Bulgarelli Peter J. Pres&CEO-LHS/EVP Office-Ventas	- 3028	55.0899 USD
6 months ago May 15, 2024	Sell 104 K USD	RAKOWICH WALTER C Director	- 2145	48.398 USD
6 months ago May 10, 2024	Sell 698 K USD	Liebbe Gregory R SVP, Chief Accounting Officer	- 14624.536	47.7043 USD
6 months ago May 07, 2024	Sell 872 K USD	Probst Robert F EVP and CFO	- 18500	47.1109 USD
1 year ago May 26, 2023	Sell 52.9 K USD	RAKOWICH WALTER C Director	- 1242	42.5688 USD
1 year ago Feb 02, 2023	Sell 1.74 M USD	CAFARO DEBRA A Chairman and CEO	- 32932	52.74 USD
1 year ago Feb 01, 2023	Sell 28.5 K USD	CAFARO DEBRA A Chairman and CEO	- 548	52.01 USD
2 years ago Jun 01, 2022	Sell 982 K USD	CAFARO DEBRA A Chairman and CEO	- 17400	56.4327 USD
2 years ago May 02, 2022	Sell 970 K USD	CAFARO DEBRA A Chairman and CEO	- 17400	55.7232 USD
2 years ago Apr 01, 2022	Sell 1.09 M USD	CAFARO DEBRA A Chairman and CEO	- 17400	62.49 USD
2 years ago Mar 29, 2022	Sell 4.41 M USD	CAFARO DEBRA A Chairman and CEO	- 69602	63.403 USD
2 years ago Mar 02, 2022	Sell 1.95 M USD	CAFARO DEBRA A Chairman and CEO	- 34800	55.9657 USD
3 years ago Nov 12, 2021	Sell 327 K USD	Reed Robert D. Director	- 5940	55.0501 USD
3 years ago Nov 10, 2021	Sell 322 K USD	SHELTON JAMES D Director	- 5940	54.1995 USD
3 years ago Sep 01, 2021	Sell 1.02 M USD	CAFARO DEBRA A Chairman and CEO	- 18075	56.628 USD
3 years ago Aug 02, 2021	Sell 1.08 M USD	CAFARO DEBRA A Chairman and CEO	- 18075	59.7738 USD
3 years ago Jul 01, 2021	Sell 1.02 M USD	CAFARO DEBRA A Chairman and CEO	- 18076	56.6175 USD
3 years ago Jun 01, 2021	Sell 1.01 M USD	CAFARO DEBRA A Chairman and CEO	- 18076	55.8183 USD
3 years ago May 03, 2021	Sell 1.01 M USD	CAFARO DEBRA A Chairman and CEO	- 18076	55.6504 USD
3 years ago Apr 01, 2021	Sell 964 K USD	CAFARO DEBRA A Chairman and CEO	- 18076	53.3343 USD
3 years ago Mar 24, 2021	Sell 162 K USD	GILCHRIST RICHARD I Director	- 2994	54.0399 USD
3 years ago Mar 11, 2021	Sell 296 K USD	Probst Robert F EVP and CFO	- 5100	58 USD
3 years ago Mar 01, 2021	Sell 972 K USD	CAFARO DEBRA A Chairman and CEO	- 18076	53.7747 USD
3 years ago Feb 26, 2021	Sell 200 K USD	Liebbe Gregory R SVP, Chief Accounting Officer	- 3700	54.04 USD
3 years ago Feb 22, 2021	Sell 281 K USD	Probst Robert F EVP and CFO	- 5200	54 USD
3 years ago Feb 01, 2021	Sell 851 K USD	CAFARO DEBRA A Chairman and CEO	- 18076	47.0516 USD
3 years ago Nov 24, 2020	Sell 275 K USD	Probst Robert F EVP and CFO	- 5500	50 USD
4 years ago Nov 12, 2020	Sell 284 K USD	SHELTON JAMES D Director	- 5940	47.8275 USD
4 years ago Nov 12, 2020	Sell 284 K USD	Reed Robert D. Director	- 5940	47.7675 USD
4 years ago Aug 11, 2020	Sell 675 K USD	Probst Robert F EVP and CFO	- 16000	42.2004 USD
4 years ago Feb 20, 2020	Sell 4.49 M USD	CAFARO DEBRA A Chairman and CEO	- 72300	62.0872 USD

7. News

Ventas to Participate in Investor Meetings at Nareit's REITworld 2024 Annual Conference CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at Nareit's REITworld 2024 Annual Conference (the “Nareit Conference”) on November 18-19, 2024. Any new or updated written materials that the Company expects to use in connection with its participation at the Nareit Conference will be made available on the Company's website on or prior to the morning of November 18, 2024. Any such materials will be. businesswire.com - 1 day ago

Ventas Announces Pricing of an Underwritten Offering of 10.6 Million Shares of Common Stock CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it priced an underwritten public offering of 10,600,000 shares of its common stock in connection with the forward sale agreement described below for gross proceeds of approximately $677 million before underwriting discounts and estimated offering expenses payable by the Company. The shares will be offered from time to time in one or more transactions on the New York Stock Exchange, in the over-th. businesswire.com - 3 days ago

Ventas Announces Underwritten Offering of 10.6 Million Shares of Common Stock CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it is commencing an underwritten public offering of 10,600,000 shares of its common stock in connection with the forward sale agreement described below. Ventas intends to grant the underwriter a 30-day option to purchase up to an additional 1,590,000 shares of its common stock. If such option is exercised, then Ventas plans to enter into an additional forward sale agreement with the forward purch. businesswire.com - 3 days ago

Here's Why Ventas Stock is an Apt Portfolio Pick for Now Rising senior citizens' population and favorable outpatient visit trends are likely to benefit VTR. zacks.com - 4 days ago

Ventas: Growth Set To Continue In The Years Ahead Ventas is a healthcare REIT focused on senior housing, outpatient medical & research, and triple-net lease properties. The Q3 2024 results were solid and the company increased its normalized FFO midpoint outlook. With a valuation above private market alternatives and distressed peers, Ventas is tapping debt and equity markets to grow its portfolio and increase normalized FFO. seekingalpha.com - 6 days ago

MOBs, Office But No Need For Life Support Unlike in traditional office, healthcare requires in-office interactions, which reduces the risk of ‘work from home'. Outpatient services are taking market share from inpatient (hospital) settings due to better costs and, in some cases, outcomes. America's rapidly aging population is a tailwind for all healthcare real estate. seekingalpha.com - 2 weeks ago

Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript seekingalpha.com - 2 weeks ago

Ventas' Q3 FFO Meet Estimates on Higher Same-Store NOI, View Raised VTR's Q3 results reflect a year-over-year rise in revenues. The total property same-store NOI improves on strong performance across the business segments. zacks.com - 2 weeks ago

Here's What Key Metrics Tell Us About Ventas (VTR) Q3 Earnings Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 weeks ago

Ventas (VTR) Q3 FFO Match Estimates Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.80 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.75 per share a year ago. zacks.com - 2 weeks ago

Healthcare REIT Ventas raises annual FFO per share forecast Healthcare REIT Ventas slightly raised the lower end of its annual funds from operations (FFO) forecast on Wednesday, expecting continued strong performance from its assisted living and senior housing properties. reuters.com - 2 weeks ago

Ventas Reports 2024 Third Quarter Results CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2024. CEO Remarks “Ventas delivered another strong quarter executing on our focused strategy to capture the unprecedented multiyear growth opportunity in senior housing,” said Debra A. Cafaro, Ventas Chairman and CEO. “We drove occupancy and revenue outperformance and double-digit NOI growth in our senior housing operating portfolio, supported by broad-. businesswire.com - 2 weeks ago

8. Profile Summary

Ventas, Inc. VTR

COUNTRY US

INDUSTRY REIT - Healthcare Facilities

MARKET CAP $ 27.7 B

Dividend Yield 1.37%

Description Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

Contact 353 North Clark Street, Chicago, IL, 60654 https://www.ventasreit.com

IPO Date May 5, 1997

Employees 486

Officers Ms. Carey Shea Roberts J.D. Executive Vice President, General Counsel, Corporate Secretary and Ethics & Compliance Officer Mr. Edmund M. Brady III Chief Human Resources Officer & Senior Vice President Mr. Brian K. Wood Chief Tax Officer & Senior Vice President Mr. T. Richard Riney J.D. Senior Advisor Mr. Peter J. Bulgarelli Executive Vice President of Outpatient Medical & Research Ms. Bhavana Devulapally Senior Vice President & Chief Information Officer Mr. Gregory R. Liebbe Senior Vice President, Chief Accounting Officer & Controller Ms. Debra A. Cafaro Chairman & Chief Executive Officer Mr. Robert F. Probst Executive Vice President & Chief Financial Officer Mr. J. Justin Hutchens Executive Vice President of Senior Housing & Chief Investment Officer

Price Chart VTR

Ventas, Inc. VTR

Premium Plan

Unlimited Plan